A phase I study of a daily x3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancer (Q33504072)
scientific article
Language:
(P31) (Q13442814)
(P304) 404-409
(P407) (Q1860)
(P433) 3
(P478) 70
(P577) Tuesday, September 1, 1998
(P921) (Q172341)
(P1433) (Q5625182)
(P1476) "A phase I study of a daily x3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancer" (language: en)
(P2093) Gershenson DM
Burke TW
Morris M
Bast RC
Guaspari A
Hohneker J
Wharton JT
other details
description scientific article

External Links